CureVac NV

( )
CVAC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.13%166.690.7%$1302.64m
PFEPfizer Inc. 1.26%39.520.9%$1071.24m
MRKMerck & Co., Inc. 0.84%79.230.7%$802.29m
ABBVAbbVie, Inc. 1.56%110.731.9%$741.70m
BMYBristol-Myers Squibb Co. 0.42%66.361.0%$695.19m
LLYEli Lilly & Co. 0.17%190.941.1%$538.28m
AZNAstraZeneca Plc 1.61%53.111.2%$522.90m
GSKGlaxoSmithKline Plc 1.43%38.240.2%$226.30m
NVSNovartis AG 0.96%88.670.2%$168.75m
VTRSViatris, Inc. 1.45%13.300.0%$124.23m
CVACCureVac NV 1.95%112.940.0%$96.87m
RGENRepligen Corp. 2.64%217.596.8%$79.40m
RPRXRoyalty Pharma Plc 3.23%42.780.2%$79.40m
NVONovo Nordisk A/S 1.24%74.190.1%$63.34m
SNYSanofi 0.89%52.460.2%$58.06m

Company Profile

CureVac BV is a clinical-stage biopharmaceutical company developing transformative medicines. It offers RNA optimization that encode functional proteins that replace defective or missing proteins using the cell's intrinsic translation machinery. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.